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494a Tuesday, March 8, 2011in contrast to greater than 10 minutes after the 254 nm UV exposure. When
a different dye: calcein-blue (Ex/Em 360/460 nm) was encapsulated in the li-
posomes, the 514 nm laser exposure treatments did not release the calcein-
blue dye suggesting the release mechanism to be wavelength specific. The
514 nm laser treatment on calcein loaded liposomes did not result in any mea-
surable chemical changes in the lipids as determined by LC-MS and morpho-
logical changes in the liposomes as determined by Cryo electron microscopy.
The 514 nm treatment of calcein-loaded liposomes also resulted in the produc-
tion of reactive oxygen species as determined through ROS assays. Moreover,
the laser-induced release of calcein was inhibited in the presence of oxygen rad-
ical scavengers. Based on these observations, we propose that visible-light trig-
gered release of entrapped solutes from DPPC/DC8,9PC liposomes occurs via
a novel mechanism that involves photo-sensitizer-generated reactive oxygen
species to perturb DC8,9PC in the liposome membrane. These formulations
are currently under investigations for drug delivery/release applications.
Membrane Active Peptides II
2683-Pos Board B669
On the Origin of Multi-Exponential Kinetics in Peptide Binding to Phos-
pholipid Vesicles
Alex Kreutzberger, Antje Pokorny.
Binding kinetics of amphipathic peptides to phospholipid bilayer vesicles are
generally well described by a single exponential function. However, closer in-
spection of the data sometimes reveals the presence of additional exponential
phases. These usually depend on the exact experimental conditions and on the
peptide studied, but are indicative of other processes that contribute to the bind-
ing kinetics. We investigated the binding of a model amphipathic peptide,
Lysette-26, to unilamellar lipid vesicles composed of 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) as a function of lipid and peptide concentra-
tion. Lysette-26 is a 22 residue peptide with the sequence IISTIGDLVK
WIIDTVKWIIDTVNKFTKK. The peptide binds well to zwitterionic lipid
bilayer membranes and forms an amphipathic a-helix when bound at the
membrane-water interface. Peptide binding was measured through fluorescence
energy transfer from the intrinsic tryptophan residue in the peptide to an acceptor
fluorophore embedded in the membrane at low concentrations. A series of exact
kinetic models was developed to describe the experimental data. We found that
the kinetics of peptide binding to POPC vesicles depended strongly on peptide
concentration in solution. The model that best described the experimental data
included the presence of peptide monomers and aggregates in solution that
bind independently andwith different rate constants to the lipid vesicles. Peptide
aggregation is favored at higher peptide concentrations, leading to the appear-
ance of an additional exponential phase. Based on the kinetic models, other pro-
cesses, such as peptide insertion or translocation across the bilayer, could be
excluded as the source of the second exponential phase in the binding kinetics.
2684-Pos Board B670
Peptides with Multiple Arginines can Spontaneously Translocate across
Lipid Vesicle Membranes and across Living Cell Membranes
Jessica R. Marks, Kalina Hristova, William C. Wimley.
Using orthogonal high-throughput screening and rational combinatorial peptide
libraries, we have identified a family of peptides that appear to spontaneously
translocate across membranes without any membrane permeabilization. The
conserved 9-residue translocation motif is mostly hydrophobic, composed of
leucine, isoleucine and proline, but also has several conserved arginine or ly-
sine residues and an open terminal amino group. Using confocal fluorescence
microscopy, we tested the ability of the selected peptides to transport a large
polar dye, TAMRA, across anionic PC/PG (90:10) vesicles and across zwitter-
ionic PC vesicles. To increase the stringency of the experiment, multilamellar
vesicles were used such that the peptides had to sequentially pass through 10-15
bilayers in order to equilibrate into the interior of the vesicles. The peptides
identified in the screen rapidly and completely equilibrated across vesicles of
either composition within about 15 minutes of addition. Binding of the peptides
to the vesicles was weak, suggesting that the small number of peptides bound at
any moment in time translocate extremely efficiently. A 3000 Da fluorescent
dextran was excluded from the vesicles, even in the presence of rapidly trans-
locating peptides. The same dye-labeled peptides also rapidly translocate
across the plasma membranes of living cells, filling the cytoplasm with a uni-
form fluorescence. Translocation was rapid, and no evidence of toxicity was
observed. We show that translocation across plasma membranes is spontane-
ous, and that endocytosis is not involved in cell penetration for these peptides.
Despite the presence of multiple arginine residues, the peptide family identified
in the orthogonal high-throughput screen rapidly translocates across synthetic
membranes and living cell membranes with a large polar dye attached. These
peptides could be used as delivery vehicles for a variety of polar drugs.2685-Pos Board B671
Characterizing the Antibacterial Mechanism of Three Novel Histone-
Derived Antimicrobial Peptides
Sara A. Spinella, SeiEun Chun, Kathryn E. Pavia, Andrew C. Webb,
Donald E. Elmore.
The rise in antibiotic resistant pathogens has sparked interest in antimicrobial
peptides (AMPs), especially those that are active against a wide variety of bac-
terial strains. Cell penetrating AMPs are of particular importance for their po-
tential as both drug delivery systems and antimicrobial agents. Buforin II (BF2)
is a well-characterized antimicrobial peptide derived from histone subunit H2A
that kills bacteria by translocating across cell membranes and binding to nu-
cleic acids. In this study, we compared the mechanisms of action of three novel
histone-derived antimicrobial peptides (HDAPs), termed DesHDAP1-3, to that
of BF2. DesHDAP1’s antibacterial potency is similar to that of BF2 across sev-
eral bacterial species, while DesHDAP2 and DesHDAP3 are generally weaker
antibacterial agents. Our current data also implies that DesHDAP1 shows in-
creased cytotoxicity against cancerous cells lines compared to BF2. Lipid ves-
icle studies measuring the translocation of all three designed peptides showed
that DesHDAP2 does not cross lipid membranes as readily as DesHDAP1,
DesHDAP3, or BF2, which may explain its poor antibacterial activity. For
comparison, we have also considered the membrane permeabilization caused
by the designed peptides using a propidium iodide uptake assay. Finally, we
have considered the role of nucleic acid binding in the mechanism of the de-
signed peptides by measuring the DNA binding and antimicrobial activity of
mutant versions of the designed peptides. This data shows that all three peptides
may not show the same correlation between DNA binding and activity ob-
served for BF2. An understanding of how the designed peptides function is
an important step in assessing their therapeutic potential and considering future
design strategies.
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Cell Penetrating Peptides. How do they Cross Membranes?
Joachim Seelig, Andre´ Ziegler, Gabriela Klocek.
Cell penetrating peptides (CPPs) are cationic peptides which, when linked to
proteins, genes, or nanoparticles, facilitate the transport of these entities across
the cell membrane. Different models have been suggested for their mode of ac-
tion. One possibility is the binding of CPPs to negatively charged lipids and the
formation of non-bilayer structures. We have studied the binding of two CPPs
(R9, HIV-1 TAT) to model membranes with isothermal titration calorimetry
and observe indeed a strong binding to the membrane. However, the bilayer re-
mains intact and non-bilayer structures can be excluded based on 2H- and 31P-
NMR spectroscopy. A second mechanism is the binding of CPPs to sulfated
sugars at the membrane surface, followed by endocytosis. We have character-
ized the binding of a large variety of CPPs to heparin sulfate (HS), heparin, and
related sulfated glycosaminoglycans (GAGs) and find binding constants in the
order of 106 - 107 M1 per binding site. An even stronger interaction is found
between CPPs and DNA with binding constants in 107 - 108 M1. We have fur-
ther synthesized a fluorescent derivative of the HIV-1 TAT protein transduction
domain (Fg-CPPTAT(PTD)) and have observed its uptake into non-fixated living
fibroblasts with time-lapse confocal microscopy. We find that Fg-CPPTAT(PTD)
enters the cytoplasm and nucleus of non-fixated fibroblasts within seconds.
With differential interference contrast microscopy we furthermore detect dense
aggregates on the cell surface. Several observations suggest that these aggre-
gates consist of Fg-CPPTAT(PTD) bound to membrane-associated heparan sul-
fate (HS). Finally a pore-forming peptide, melittin, also binds to sulfated
GAGs but not magainin 2 or nisin Z. The binding of the melittin to lipid bila-
yers is furthermore an excellent model system to elucidate the thermodynamic
parameters of membrane-induced a-helix and b-sheet formation.
.
2687-Pos Board B673
AFM Force Spectroscopy on TAT Membrane Penetration
Elizabeth A. Hager-Barnard, Benjamin D. Almquist, Nicholas A. Melosh.
We present a combined experimental and theoretical study of the interactions
between cell-penetrating peptides (CPPs) and lipid bilayers using dynamic
AFM measurements. Understanding how CPPs can pass through cell mem-
branes is critical for designing drug delivery agents. While CPPs like HIV-
TAT have been widely studied, their ability to penetrate membranes directly,
without active transport, is still a matter of considerable debate. Here, we di-
rectly measure TAT-lipid mechanics during the actual membrane translocation
event using TAT-functionalized AFM probes to penetrate through a stack of
lipid bilayers. Dynamic force spectroscopy revealed that both the bilayer break-
through force and bilayer thickness depended on the TAT-bilayer contact time.
The results provide a detailed view of how TAT interacts with the bilayer.
Upon contact, TAT inserts into the bilayer headgroup to a depth of ~1nm in
